International Companies

Novo Nordisk files lawsuit against Eli Lilly for 'misleading' weight-loss drug ads

By Benjamin Chiou

Date: Tuesday 21 Jul 2026

(Sharecast News) - Danish pharma group Novo Nordisk has launched legal action against rival Eli Lilly & Co, accusing it of using "misleading" and "deceptive" advertising for its weight-loss drugs.
Novo Nordisk said it has filed a suit in the US District Court in New Jersey for "multiple violations of...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page